Poland · Delayed Price · Currency is PLN Genomtec Statistics
Total Valuation
Genomtec has a market cap or net worth of PLN 44.82 million. The enterprise value is 31.76 million.
| Market Cap | 44.82M |
| Enterprise Value | 31.76M |
Important Dates
The last earnings date was Wednesday, September 30, 2026.
| Earnings Date | Sep 30, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Genomtec has 15.06 million shares outstanding.
| Current Share Class | 15.06M |
| Shares Outstanding | 15.06M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 19.49% |
| Owned by Institutions (%) | 3.32% |
| Float | 9.77M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1,282.65 |
| PB Ratio | 2.86 |
| P/TBV Ratio | 3.69 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.05, with a Debt / Equity ratio of 0.08.
| Current Ratio | 4.05 |
| Quick Ratio | 3.78 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -53.46 |
Financial Efficiency
Return on equity (ROE) is -55.54% and return on invested capital (ROIC) is -28.50%.
| Return on Equity (ROE) | -55.54% |
| Return on Assets (ROA) | -22.69% |
| Return on Invested Capital (ROIC) | -28.50% |
| Return on Capital Employed (ROCE) | -42.85% |
| Weighted Average Cost of Capital (WACC) | 6.14% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 32 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -34,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -54.64% in the last 52 weeks. The beta is 0.33, so Genomtec's price volatility has been lower than the market average.
| Beta (5Y) | 0.33 |
| 52-Week Price Change | -54.64% |
| 50-Day Moving Average | 3.57 |
| 200-Day Moving Average | 4.48 |
| Relative Strength Index (RSI) | 31.32 |
| Average Volume (20 Days) | 23,115 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Genomtec had revenue of PLN 35,000 and -7.93 million in losses.
| Revenue | 35,000 |
| Gross Profit | -7.10M |
| Operating Income | -7.32M |
| Pretax Income | -7.97M |
| Net Income | -7.93M |
| EBITDA | -4.96M |
| EBIT | -7.32M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 14.24 million in cash and 1.19 million in debt, with a net cash position of 13.06 million or 0.87 per share.
| Cash & Cash Equivalents | 14.24M |
| Total Debt | 1.19M |
| Net Cash | 13.06M |
| Net Cash Per Share | 0.87 |
| Equity (Book Value) | 15.67M |
| Book Value Per Share | n/a |
| Working Capital | 12.14M |
Cash Flow
In the last 12 months, operating cash flow was -4.89 million and capital expenditures -80,000, giving a free cash flow of -4.97 million.
| Operating Cash Flow | -4.89M |
| Capital Expenditures | -80,000 |
| Depreciation & Amortization | 2.37M |
| Net Borrowing | -987,000 |
| Free Cash Flow | -4.97M |
| FCF Per Share | -0.33 |
Margins
| Gross Margin | n/a |
| Operating Margin | -20,925.71% |
| Pretax Margin | -22,765.71% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Genomtec does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -17.67% |
| FCF Yield | -11.08% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |